Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03481205 · ClinicalTrials.gov registry record · NA

Ischemic Conditioning During Air tRansport Save penUmbral Tissue

A NA study of Acute Stroke, sponsored by Enrique Leira.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03481205 is a NA study of Acute Stroke that is actively recruiting participants, run by Enrique Leira. The registered enrollment target is 10 participants, below the 6,125-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03481205, a NA study of Acute Stroke, is actively recruiting participants, sponsored by Enrique Leira.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to demonstrate the feasibility of performing remote limb ischemic conditioning (RLIC) using the Doctormate device, a special blood pressure device used to perform RLIC, on patients with acute ischemic stroke due to large vessel occlusion being transported to a thrombectomy capable center by the helicopter.

Conditions Studied

Interventions

  • DEVICE Ischemic conditioning device

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2020-06-01
Est. Completion 2026-12-31
Phase NA

Sponsor

Enrique Leira

1 total trials

What the Registry Record Tells You About NCT03481205

The ClinicalTrials.gov registry entry for NCT03481205 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,125-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Enrique Leira, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Stroke appearing as the primary indexed condition, and to 1 intervention - of which Ischemic conditioning device is the first listed.

NCT03481205 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT03481205 about?

NCT03481205 is a clinical study titled "Ischemic Conditioning During Air tRansport Save penUmbral Tissue". The purpose of this study is to demonstrate the feasibility of performing remote limb ischemic conditioning (RLIC) using the Doctormate device, a special blood pressure device used to perform RLIC, on patients with acute ischemic stroke due to large vessel occlusion being transported to a thrombecto...

What is the current status of trial NCT03481205?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2020-06-01. Estimated completion is 2026-12-31.

What conditions does trial NCT03481205 study?

This clinical trial studies the following conditions: Acute Stroke.

What interventions are being tested in trial NCT03481205?

The interventions under investigation include: Ischemic conditioning device (DEVICE).

Who is sponsoring clinical trial NCT03481205?

This trial is sponsored by Enrique Leira, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03481205 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.